Screener
D&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Phibro Animal Health in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Phibro Animal Health’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:25 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056280
| For the Periods Ended March 31 | Three Months / 2026 | Three Months / 2025 | Nine Months / 2026 | Nine Months / 2025 |
|---|---|---|---|---|
| Depreciation and amortization | ||||
| Depreciation of property, plant and equipment | $10,726 | $10,897 | $33,025 | $27,048 |
| Amortization of intangible assets | 1,722 | 1,719 | 5,144 | 6,146 |
| $12,448 | $12,616 | $38,169 | $33,194 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Phibro Animal Health's D&A?
- Phibro Animal Health (PAHC) reported D&A of $12.45M in Q1 2026.
- How has Phibro Animal Health's D&A changed year-over-year?
- Phibro Animal Health's D&A decreased by 1.3% year-over-year, from $12.62M to $12.45M.
- What is the long-term trend for Phibro Animal Health's D&A?
- Over 3 years (2022 to 2025), Phibro Animal Health's D&A has grown at a 11.7% compound annual growth rate (CAGR), from $32.71M to $45.61M.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.
Ask your AI about Phibro Animal Health's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude